Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lionco Pharmaceutical Group is a China-based pharmaceutical manufacturer and commercial-stage drug company focused primarily on prescription chemical medicines. Public sources describe the company as engaged in the research, development, production, and sale of products spanning parenteral nutrition, anti-infective, digestive, cardiovascular, cerebrovascular, detoxification, antiviral, and anti-tumor categories. Its marketed portfolio appears to include multiple dosage forms such as tablets, liquids, ointments, and injectable products, with injectables representing an important part of the business. The company is publicly traded in Shanghai and operates mainly in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lionco Pharmaceutical Group.